Ovarian cancer
Conditions
Interventions
experimental group:Nutrition risk screening and Nutritional intervention
Sponsors
He'nan Cancer Hospital
Eligibility
Sex/Gender
Female
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Patients with primary ovarian cancer, salpingocarcinoma and primary peritoneal cancer who plan to receive chemotherapy after tumor cell reduction; 2. Patients with residual focus = 3.0 x 10^9 / L, neutrophil count >= 1.5 x 10^9 / L, platelet count >= 100 x 10^9 / L, hemoglobin >= 80 g / L; 6. Organ function is good, biochemical examination meets the following conditions: AST <= 2.5 x upper limit of normal value (ULN), ALT <= 2.5 x upper limit of normal value (ULN), serum total bilirubin <= 1.5 x upper limit of normal value (ULN), creatinine <= 1.5 x upper limit of normal value (ULN); 7. Function status: 0-1 (ECoG); 8. Patients who voluntarily sign informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with other malignant tumors within 5 years; 2. Patients with other serious diseases that are difficult to control (including atrial fibrillation, angina pectoris, cardiac insufficiency, ejection fraction less than 50%, uncontrolled hypertension, renal insufficiency, uncontrollable infection, etc.); 3. Patients who are being treated with anticancer drugs in other clinical trials; 4. Any unstable condition or situation that may endanger the safety and compliance of patients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| whole body fat-free mass index without bone; | — |
Secondary
| Measure | Time frame |
|---|---|
| chemotherapy adverse reaction;Quality of life;Progression-free survival; | — |
Countries
China
Contacts
Public ContactDingxi Li
He'nan Cancer Hospital
Outcome results
None listed